23.80
+0.21%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Allied Biotech
Its shares trade on Taipei Exchange under the ticker 1780.TWO. It has been listed since 29 April 2010. In the fiscal year to 31 December 2025, it reported revenue of TWD 849.5m and net income of TWD 129.5m. At that date it held total assets of TWD 2.09bn and shareholders' equity of TWD 1.23bn.
Allied Biotech Corp. engages in the manufacture of carotenoid formulations for food, supplement, feeds, and cosmetics. The company is headquartered in Taipei City, Taipei. The company went IPO on 2010-04-29. The firm's nutraceutical products include healthcare products for human, nutraceutical products for animals, veterinary drugs, pharmaceutical cosmetics and biotechnology products, among others. Its carotenoids are applied in the processing of food and beverage products. Its major products include beta-carotene, canthaxanthin, lycopene, lutein, coenzyme Q10, natural vitamin E and food additives, among others. The firm distributes its products within domestic market and to overseas markets, including the rest of Asia, Europe and the Americas.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 29 Apr 2010
- Employees
- 130
- Website
- altratene.com ↗
Leadership
Pay as last reported
- Mr. Cheng-Li YangChairman of the Board, since 2002
- Mr. Bin YangChief Operating Officer
- Mr. Qinghui LinGeneral Manager, since 2002
- Ms. Xinghui YangHead of Finance & Accounting, Corporate Governance Officer
- Yongxian ChengChief Information Security Officer
- Mr. Yung-Shun ChuangDirector
- Ms. Rongmin GongDirector
- Mr. Shih-Chinn HoDirector
- Ms. Lih-Fen LuoDirector
- Jiachong WangDirector
- Xiujin XinDirector
- Mr. Qingkun ChenIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Allied Biotech Corp manufactures diverse carotenoid formulations for multiple industries.
- The firm produces beta-carotene and lycopene for food processing applications.
- Products include nutraceuticals for humans and veterinary drugs for animals.
Weaknesses
- The company has only 130 employees, limiting operational scale.
- Reliance on domestic market distribution may restrict immediate growth potential.
- Product range focuses heavily on specific carotenoids rather than broad segments.
Opportunities
- Expanding distribution to Europe and the Americas increases global reach.
- Growing demand for natural vitamin E supports product sales growth.
- Coenzyme Q10 applications in cosmetics offer new revenue streams.
Threats
- Competition in the biotechnology sector may pressure pricing strategies.
- Regulatory changes in Asia could impact domestic market operations.
- Fluctuating raw material costs affect manufacturing profitability margins.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.